Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative
CAC 40 : la Bourse se prépare aux annonces de la BCE et de la Fed capital.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capital.fr Daily Mail and Mail on Sunday newspapers.